Does CARBIDOPA\LEVODOPA Cause Psychomotor hyperactivity? 196 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Psychomotor hyperactivity have been filed in association with CARBIDOPA\LEVODOPA. This represents 0.3% of all adverse event reports for CARBIDOPA\LEVODOPA.
196
Reports of Psychomotor hyperactivity with CARBIDOPA\LEVODOPA
0.3%
of all CARBIDOPA\LEVODOPA reports
8
Deaths
103
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From CARBIDOPA\LEVODOPA?
Of the 196 reports, 8 (4.1%) resulted in death, 103 (52.6%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBIDOPA\LEVODOPA. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does CARBIDOPA\LEVODOPA Cause?
Fall (7,132)
Death (5,403)
Dyskinesia (5,368)
Tremor (3,689)
General physical health deterioration (3,636)
On and off phenomenon (3,509)
Hallucination (3,367)
Drug ineffective (3,205)
Parkinson's disease (3,140)
Device dislocation (2,937)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which CARBIDOPA\LEVODOPA Alternatives Have Lower Psychomotor hyperactivity Risk?
CARBIDOPA\LEVODOPA vs CARBIMAZOLE
CARBIDOPA\LEVODOPA vs CARBOCYSTEINE
CARBIDOPA\LEVODOPA vs CARBOMER
CARBIDOPA\LEVODOPA vs CARBON DIOXIDE
CARBIDOPA\LEVODOPA vs CARBON MONOXIDE